What Kind Of Shareholders Own Clal Biotechnology Industries Ltd. (TLV:CBI)?
Every investor in Clal Biotechnology Industries Ltd. (TLV:CBI) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. Companies that used to be publicly owned tend to have lower insider ownership.
With a market capitalization of ₪321m, Clal Biotechnology Industries is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutions are noticeable on the share registry. Let’s delve deeper into each type of owner, to discover more about Clal Biotechnology Industries.
What Does The Institutional Ownership Tell Us About Clal Biotechnology Industries?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
Clal Biotechnology Industries already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Clal Biotechnology Industries, (below). Of course, keep in mind that there are other factors to consider, too.
Hedge funds don’t have many shares in Clal Biotechnology Industries. Our data shows that Clal Industries Ltd., Investment Arm is the largest shareholder with 47% of shares outstanding. Teva Pharmaceutical Industries Limited is the second largest shareholder owning 15% of common stock, and Meitav DASH Investments Ltd holds about 4.6% of the company stock.
To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.
Researching institutional ownership is a good way to gauge and filter a stock’s expected performance. The same can be achieved by studying analyst sentiments. We’re not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.
Insider Ownership Of Clal Biotechnology Industries
The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
Most consider insider ownership a positive because it can…